Home / Technology / Withings BodyScan 2: Longevity Station Launched
Withings BodyScan 2: Longevity Station Launched
19 Sep
Summary
- The BodyScan 2 is the first longevity station measuring cardiometabolic health.
- It offers SpO2, hypertension screening, and heart age estimations.
- The scale costs $599.95 and requires a $9.95 monthly subscription for full features.
The Withings BodyScan 2 marks a significant innovation in personal health tracking, presented as the 'world's first longevity station'. This advanced scale goes beyond typical weight and body composition analysis, offering a complete cardiometabolic assessment with each weigh-in. It aims to help users understand how their lifestyle choices impact their long-term healthy life expectancy.
Building on its predecessor, the BodyScan 2 introduces several key features previously unseen in consumer devices. These include blood oxygen (SpO2) measurements, hypertension screening, and estimations of heart and vascular age. A forthcoming update will also add reporting on the risk of unstable glycaemia.
This cutting-edge technology comes at a premium price. The BodyScan 2 retails for $599.95 USD / £449.95 GBP / $895 AUS. Furthermore, unlocking the full suite of advanced features, including personalized health insights and AI-driven progress assessments, necessitates a monthly Withings+ subscription of $9.95 / £8.95.
Despite its high cost, the BodyScan 2 boasts exceptional build quality with a reinforced aluminum chassis and a high-resolution LCD screen integrated into its retractable handle. It tracks over 40 biomarkers, combining smartwatch technology with smart scale functionality for unparalleled consumer-level analysis.
